Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin.

about

Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin.

Item

http://www.wikidata.org/entity/Q49193708

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparative Study on Adding Pi ...... tly Controlled With Metformin.

@en

Comparative Study on Adding Pi ...... tly Controlled With Metformin.

@nl

type

Item

label

Comparative Study on Adding Pi ...... tly Controlled With Metformin.

@en

Comparative Study on Adding Pi ...... tly Controlled With Metformin.

@nl

prefLabel

Comparative Study on Adding Pi ...... tly Controlled With Metformin.

@en

Comparative Study on Adding Pi ...... tly Controlled With Metformin.

@nl

P1476

Comparative Study on Adding Pi ...... tly Controlled With Metformin.

@en

P2093

Maryam Jameshorani

http://www.w3.org/2001/XMLSchema#string

Narjes Kiahashemi

http://www.w3.org/2001/XMLSchema#string

Saba Sayari

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Mechanisms linking obesity to insulin resistance and type 2 diabetes

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.

Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?

Sitagliptin: a review of its use in the management of type 2 diabetes mellitus.

Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.

P304

955-962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3889/OAMJMS.2017.193

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nima Motamed

P577

2017-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29362626

http://www.w3.org/2001/XMLSchema#string

P921

metformin

type-2 diabetes

P932

5771302

http://www.w3.org/2001/XMLSchema#string